Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Romidepsin Maintenance after Allogeneic Stem Cell Transplantation

Protocol: OSU-16242

Full Title

Romidepsin Therapy in Conditioning and Maintenance in Patients with T-Cell Malignancies Receiving Allogeneic Stem Cell Transplant

For More Information

See Full Trial at ClinicalTrials.gov
Email This Trial to Your Physician to Verify Eligibility
Print a Copy of This Trial
Learn More About Clinical Trial Phases
Protocol Page
Leukemia Lymphoma Cutaneous Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell)